Back
NovoCure Ltd. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
NVCR
NovoCure Ltd.
Last Price:
$10.54
Seasonality Move:
18.48%
7 Day Trial
ALL ACCESS PASS
$
7
NovoCure Ltd. Stock Forecast
-
Over the next 52 weeks, NovoCure Ltd. has on average historically risen by 22.1% based on the past 10 years of stock performance.
-
NovoCure Ltd. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is NovoCure Ltd. Stock Undervalued?The current NovoCure Ltd. [NVCR] share price is $10.55. The Score for NVCR is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
NVCR is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will NovoCure Ltd. Stock Go Up Next Year?
-
Over the next 52 weeks, NovoCure Ltd. has on average historically risen by 22.1% based on the past 10 years of stock performance.
NovoCure Ltd. Stock Rating
Sell
27
NovoCure Ltd. (NVCR)
is a Sell
Is NovoCure Ltd. overpriced?
-
NovoCure Ltd. has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
NovoCure Ltd. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United Kingdom
Industry:
Health Care Equipment & Supplies
Sector:
Health Care
Type:
stock
Website:
novocure.com
52-Week Data
52-Week High:
20.06
52-Week Low:
9.82
Prediction Charts
Market Cap:
1.2B
Price in USD:
10.55
Volume:
1.1M
Beta:
1.04
Technical Analysis
SMA50:
12.06
SMA100:
12.40
SMA200:
13.07
52-Wk Change:
-41.19%
Stock Predictions
-
Is NovoCure Ltd. stock public?Yes, NovoCure Ltd. is a publicly traded company.
-
What is the NovoCure Ltd. stock quote today?The NovoCure Ltd. stock price is 10.55 USD today.
-
How to buy NovoCure Ltd. stock online?You can buy NovoCure Ltd. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-16 | 12.24 | 12.38 | 12.58 | 12.17 |
| Mar-17 | 12.49 | 12.35 | 12.84 | 12.30 |
| Mar-18 | 11.97 | 12.06 | 12.30 | 11.79 |
| Mar-19 | 12.21 | 12.15 | 12.37 | 11.93 |
| Mar-20 | 12.14 | 11.81 | 12.14 | 11.46 |
| Mar-23 | 11.94 | 11.82 | 12.19 | 11.63 |
| Mar-24 | 11.59 | 11.36 | 11.71 | 11.24 |
| Mar-25 | 11.65 | 11.61 | 11.83 | 11.47 |
| Mar-26 | 11.80 | 11.76 | 12.30 | 11.41 |
| Mar-27 | 11.62 | 10.97 | 11.62 | 10.94 |
| Mar-30 | 10.92 | 10.36 | 11.01 | 10.32 |
| Mar-31 | 10.42 | 10.90 | 10.94 | 10.25 |
| Apr-1 | 11.03 | 10.84 | 11.30 | 10.84 |
| Apr-2 | 10.52 | 10.55 | 10.87 | 10.30 |
NovoCure Ltd. Earnings
NovoCure Ltd. Earnings Report: Per Share NovoCure Ltd. Earnings Q1 Q2 Q3 and Q4 last year and next year.
NovoCure Ltd. Forecast Revenue Growth
NovoCure Ltd. Stock Analysis: Historical quarterly revenues per share for NovoCure Ltd. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.13 per share, and an increase next year of $0.37 per share.
* NovoCure Ltd. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.